All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @semaglutideandsanity on TikTok · 79s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @semaglutideandsanity's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Here's everything I ate today is a 46-year-old mom on a GLP 1 down 45 pounds.
  2. 0:06When I don't know what the rest of the day holds, I always start my day with this shake
  3. 0:10because I know that it gives me plenty of protein to start my day and will keep me full
  4. 0:15until whenever I eat it.
  5. 0:16If you're interested in the rest, it is pinned at the top of my page.
  6. 0:20I have this shake almost every day of the week.
  7. 0:22The chocolate peanut butter combo is just ugh.
  8. 0:24For lunch, I had what I call my chicken parmesan.
  9. 0:27I take a half a cup of cottage cheese and a half a cup of rheos marinara and mix it together
  10. 0:32and then microwave it to warm it up.
  11. 0:34You can put it in a pot if you prefer that.
  12. 0:36And since people like to point out that I don't eat enough fruits or vegetables, I'm having
  13. 0:39some blueberries too.
  14. 0:40Once the sauce is warmed, I add some lightly breaded chicken nuggets and then top that with
  15. 0:44Parmesan cheese.
  16. 0:45Mmm, mm yummy.
  17. 0:47This is also delicious if you add a little bit of pasta or rice.
  18. 0:50And look at me enjoying these blueberries.
  19. 0:52As an afternoon snack, I had one of these bear bells cookies and cream protein bars.
  20. 0:57They have 20 grams of protein and 4 grams of fiber.
  21. 1:00They are one of the best protein bars out there.
  22. 1:03And finally for dinner, we had in and out.
  23. 1:05I got a double double protein style and I shared a fry with my youngest.
  24. 1:09I do not eat out very often, but this was delicious.
  25. 1:12And just goes to show you that you can pretty much eat anything you want as long as you fit
  26. 1:17it in to your macros.

High-protein, high-fiber eating on GLP-1s: what the evidence says

SemaglutideandSanity❤️‍🩹

TikTok creator

452.0K viewsWatch on TikTok

Quick answer

The creator is using a GLP-1 receptor agonist for weight management and has lost 45 pounds, which is consistent with outcomes reported in clinical trials for semaglutide and similar agents. Her dietary approach of prioritizing high protein and high fiber is broadly aligned with evidence-based nutritional guidance for patients on GLP-1 therapy, particularly to mitigate lean mass loss during caloric restriction. Her claim that food choice is unrestricted provided macros are met is an oversimplification that does not account for GI tolerability, food quality, or the unique metabolic context of GLP-1-mediated gastric emptying changes.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 9 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For High-protein, high-fiber eating on GLP-1s: what the evidence says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

High-protein, high-fiber eating on GLP-1s: what the evidence says is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "High-protein, high-fiber eating on GLP-1s: what the evidence says" from SemaglutideandSanity❤️‍🩹. We read the clip as a GLP-1 social video fact-checks claim about GLP-1 social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator is using a GLP-1 receptor agonist for weight management and has lost 45 pounds, which is consistent with outcomes reported in clinical trials for semaglutide and similar agents.

The reason this review is not generic is the source wording and the canonical claim label "glp1 here s everything i eat in a day on a gl p one down 45 i foc." In this clip, the useful excerpt is: "Here's everything I ate today is a 46-year-old mom on a GLP 1 down 45 pounds." That wording changes the review because it points to GLP-1 social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. GLP-1 social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Gardner et al.
People who land here are usually comparing the GLP-1 social video fact-checks claim with [object Object].
The strongest next step is to compare the claim with FormBlends' GLP-1 social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator is using a GLP-1 receptor agonist for weight management and has lost 45 pounds, which is consistent with outcomes reported in clinical trials for semaglutide and similar agents.

FormBlends verdict

GLP-1 social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator is using a GLP-1 receptor agonist for weight management and has lost 45 pounds, which is consistent with outcomes reported in clinical trials for semaglutide and similar agents. Her dietary approach of prioritizing high protein and high fiber is broadly aligned with evidence-based nutritional guidance for patients on GLP-1 therapy, particularly to mitigate lean mass loss during caloric restriction. Her claim that food choice is unrestricted provided macros are met is an oversimplification that does not account for GI tolerability, food quality, or the unique metabolic context of GLP-1-mediated gastric emptying changes.
  • Protein intake of 1.2 to 1.6g per kilogram of body weight is commonly recommended in bariatric nutrition contexts to prevent lean mass loss during GLP-1-assisted weight loss.
  • Gardner et al. (2018, JAMA) found no clear superiority of low-fat versus low-carb diets when protein was matched, giving some basis to a macro-focused approach.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Protein intake of 1.2 to 1.6g per kilogram of body weight is commonly recommended in bariatric nutrition contexts to prevent lean mass loss during GLP-1-assisted weight loss.
  • Gardner et al. (2018, JAMA) found no clear superiority of low-fat versus low-carb diets when protein was matched, giving some basis to a macro-focused approach.
  • GLP-1 medications slow gastric emptying, which means high-fat meals can worsen nausea and GI side effects, a factor that 'fitting macros' does not capture.
  • Jensterle et al. (2023, Obesity Reviews) found dietary quality, not macros alone, influenced tolerability and outcomes in patients on GLP-1 receptor agonist therapy.
  • Hydration is a documented risk area for GLP-1 users because appetite suppression reduces both food and fluid intake simultaneously, yet it was not mentioned in this video.
  • Cottage cheese as a protein base is a legitimate, evidence-adjacent choice: it delivers high protein with low caloric density, which suits the reduced appetite context of GLP-1 use.
  • Davies et al. (2021, Lancet Diabetes and Endocrinology) linked sustained semaglutide outcomes to lifestyle factors including diet quality, suggesting food choice matters beyond the macro numbers.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @semaglutideandsanity actually say?

The creator, a 46-year-old woman down 45 pounds on a GLP-1 medication, walked through a full day of eating: a protein shake, a cottage cheese "chicken parmesan," a protein bar, and an In-N-Out double double protein style. Her central claim is the one worth examining: "you can pretty much eat anything you want as long as you fit it in to your macros."

She frames her approach around high protein and high fiber, which checks out based on the foods shown. The protein bar had 20g protein and 4g fiber. The cottage cheese base is a legitimate protein source. The protein-style burger swap cuts refined carbs. These are reasonable, practical choices for someone managing appetite on a GLP-1. But that closing line about eating anything as long as macros fit is where things get complicated.

Does the science back this up?

The macro-flexibility claim is partially supported, but it's missing important context that matters a lot for GLP-1 users specifically. The broader research on flexible dietary approaches does show benefit. Gardner et al. (2018, JAMA) found that neither low-fat nor low-carb diets were clearly superior for weight loss when protein was kept high. So macro-focused eating has a legitimate evidence base.

However, GLP-1 receptor agonists slow gastric emptying, which changes how your body processes different foods. Hjerpsted et al. and subsequent clinical work have shown that high-fat, high-sugar ultra-processed foods can worsen GI side effects common with semaglutide, including nausea and delayed gastric emptying. A 2023 review in Obesity Reviews by Jensterle et al. noted that dietary quality, not just macros, appears to influence both tolerability and long-term outcomes on GLP-1 therapy. Calories and protein matter, but food quality is not irrelevant on these medications.

What did they get wrong (or right)?

Credit where it's due: the high-protein, high-fiber framework she describes is genuinely well-matched to GLP-1 use. Protein preserves lean muscle during rapid weight loss, which is a real concern. Baraldi et al. (2022, Nutrients) found that inadequate protein intake during GLP-1-assisted weight loss accelerated lean mass decline. Her choices, cottage cheese, protein bars, grilled protein, reflect awareness of this risk.

The "eat anything you want" line is where she oversimplifies. Macros are a useful tool, but they don't capture food quality, glycemic impact, or GI tolerability. For someone new to GLP-1 medications who takes this literally and loads up on high-fat fast food daily because the protein number fits, that's a recipe for side effects and potentially suboptimal metabolic outcomes. The In-N-Out meal as an occasional choice is defensible. As a framework for how to eat on these medications, it's incomplete advice.

Also worth noting: she doesn't mention hydration, which is a real issue on GLP-1 medications where appetite suppression can reduce fluid intake alongside food intake.

What should you actually know?

GLP-1 medications suppress appetite significantly, which means the foods you do eat carry more nutritional weight per calorie consumed. When you're eating less overall, the quality of what you eat becomes more important, not less. Protein targets of 1.2 to 1.6g per kilogram of body weight are commonly cited in bariatric and obesity medicine contexts to protect muscle mass during GLP-1-assisted loss.

Fiber matters too, but the source matters. The 4g fiber from a processed protein bar is not equivalent to fiber from vegetables, legumes, or whole grains in terms of gut microbiome impact or satiety signaling. Davies et al. (2021, Lancet Diabetes and Endocrinology) showed sustained semaglutide benefit was tied to lifestyle factors including diet quality, not macros alone.

If you're on a GLP-1 and trying to build a meal approach, high protein and high fiber are genuinely good anchors. But "fit it in your macros" is not a complete strategy. Food quality, GI tolerability, and consistent hydration all belong in that conversation, and none of them show up in a macro tracker.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

SemaglutideandSanity❤️‍🩹 · TikTok creator

452.0K views on this video

Here’s everything I eat in a day on a GL P one down -45. I focus on high protein high fiber so if you are looking for meal ideas or recipes, follow along! #wieiad #glp1community #highproteinmeals #highfiber #glp1journey

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about protein intake of 1.2 to 1.6g per kilogram of body?

Protein intake of 1.2 to 1.6g per kilogram of body weight is commonly recommended in bariatric nutrition contexts to prevent lean mass loss during GLP-1-assisted weight loss.

What does the video say about gardner et al. (2018, jama) found no clear superiority of?

Gardner et al. (2018, JAMA) found no clear superiority of low-fat versus low-carb diets when protein was matched, giving some basis to a macro-focused approach.

What does the video say about glp-1 medications slow gastric emptying,?

GLP-1 medications slow gastric emptying, which means high-fat meals can worsen nausea and GI side effects, a factor that 'fitting macros' does not capture.

What does the video say about jensterle et al. (2023, obesity reviews) found dietary quality, not?

Jensterle et al. (2023, Obesity Reviews) found dietary quality, not macros alone, influenced tolerability and outcomes in patients on GLP-1 receptor agonist therapy.

What does the video say about hydration?

Hydration is a documented risk area for GLP-1 users because appetite suppression reduces both food and fluid intake simultaneously, yet it was not mentioned in this video.

What does the video say about cottage cheese as a protein base?

Cottage cheese as a protein base is a legitimate, evidence-adjacent choice: it delivers high protein with low caloric density, which suits the reduced appetite context of GLP-1 use.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by SemaglutideandSanity❤️‍🩹, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.